Table Of Content

PROSTAGLANDINS & other LIPID MEDIATORS Prostaglandins & other Lipid Mediators 66 (2001) 345-345 Author Index Akimoto K., 109 Inoue Y., 1 Mori Y., 89 Albrecht E.D., 155 Itoh M., 221 Mphata P.R., 53 Arakawa H., 1 Itoh Y., 221 Murase K., 89 Balabanova L., 145 Iwata H., 89 Nagasaka A., 221 Basini G., 179 Johnson C., 305 Nakai A., 221 Berry E.B.E., 265 Jozkowicz A., 165 Nanobashvili J., 165 Bridges P.J., 77 Kakizawa H., 221 Nigisch A., 165 Chen M.-F., 99 Kato M., 1 Nijmeijer B.E., 265 Ching L., 77 Kato T., 221 Nishimura H., 1 Claassen N., 53 Kearns S.D., 53 Ochi T., 317 Clay K.L., 305 Keelan J.A., 17, 265 Pepe G.J., 155 Dinauer M.C., 305 Kiso Y., 109 Plonka A., 39 Doshi M., 109 Konturek P.C., 39 Prager M., 165 Duda A., 39 Konturek S.J., 39 Queralt J., 27 Dulak J., 165 Kruger M.C., 53 Rosenthal M.D., 155 Fujiwara K., 221 Kummerow F.A., 283 Sasser R.G., 77 Fukumoto Y., 89 Lamont R.F., 203 Sato T.A., 17, 265 Gilmour R.S., 265 LeaMaster B.R., 77 Sito E., 39 Gordon H., 203 Lee Y.-T., 99 Takagi H., 89 Goto T., 317 Leffler C.W., 145 Tamanini C., 179 Gupta D.K., 17 Levin R.M., 211 Tokuyama K., 1 Haag M., 53 Logue M., 203 Travers J.B., 305 Hahn E.G., 39 Magada O.N., 53 Turull A., 27 Hamazaki T., 109 Mahfouz M.M., 283 Umeda Y., 89 Hass M.A., 211 Makino M., 221 Watanabe S., 109 Helliwell R.J.A., 265 Marvin K.W., 17, 265 Weems C.W., 77 Hiran T.S., 305 Masick J.M., 211 Weems Y.S., 77 Hirose H., 89 Mitchell M.D., 17, 265 Weigel G., 165 Hishida H., 221 Miyauchi T., 89 Winter B., 165 Hsu H.-C., 99 Mochizuki H., 1 Yamamoto K., 221 Huk I., 165 Morgan D.J., 203 Yasui T., 221 Imamura S., 221 Morikawa A., 1 Zuchowicz M., 39 PII: S0090-6980(99)00052-0 PROSTAGLANDINS & other LIPID MEDIATORS Prostaglandins & other Lipid Mediators 66 (2001) 347-347 Subject Index 15-deoxy-A!*!4-PGJ,, 265 Fish oil, 99 PGHS-2, 17 Anterior spinal artery, 89 fMLP, 305 Phospholipase C, 145 Anti-inflammation, 317 FR140423, 317 Placenta, 17 antioxidants, 283 Gastrin, 39 Plasma exudation, 1 Aortic cross-claniping, 89 Gastrin receptors, 39 Plasma leakage, 1 Apoptosis, 265 Glutathione, 99 Platelet-activating factor, Arachidonic acid, 53, 109 Granulocytes, 305 109, 305 Ca**-ATPase, 53 Helicobacter pylori Pregnancy, 17 CCK,-R, 39 Gastric ulcer, 39 Prostacyclin, 145, 283 Charge-coupled device, 89 Hypercholesterolemia, 99 Prostaglandin El, 89 chronic granulomatous Iloprost, 145 Prostaglandin formation, disease, 305 lysophosphatidylcholine, 317 COX-1, 39 283 Prostaglandins, 17, 39 COX-2, 39 Mouse, 17, 109 Rabbit, 89 Cyclic AMP, 145 Na’ ,K*-ATPase, 53 Rabbits, 99 Cyclooxygenase-2, 317 NADPH oxidase, 305 Rat aorta, 283 Docosahexaenoic acid, oxidized low density Rosiglitazone, 265 109 lipoprotein, 283 Type II collagen arthritis, Duodenal Ca absorption, oxysterols, 283 317 53 Peritoneal cells, 109 Vascular leakage, 1 Eicosatrienoic acid, 109 Peroxisome proliferator- Endothelial gap, 1 activated receptor-y, Vitamin E, 99 Fatty acid composition, 265 WISH cells, 265 109 PGHS-1, 17 PII: S0090-6980(99)00052-0